Company / PP&E (Net)
IONIS PHARMACEUTICALS INC PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$123.0M
FY2025
5-year range
$71.0M / $178.1M
FY2021-FY2025
Trend
+30.6%
vs FY2024
Sector context
#39 of 193
Health Care
What the data says
IONIS PHARMACEUTICALS INC's pp&e (net) of $123M is higher than 80% of companies in the Health Care sector (FY2025). Improved from $71M to $123M over the past 2 years.
Based on SEC 10-K filings.
$123M in FY2025 with a 5-year CAGR of -7.4%. Top quartile in the Health Care sector.
Improved from $71M to $123M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +18.3%
- 5-Year CAGR
- -7.4%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 193This company $123.0M Sector average $777.6M
▼
-84.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -7.4%, indicating a declining trend.
- In FY2025, pp&e (net) increased 30.6% year-over-year.
- Ranks #39 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $123.0M | +30.6% |
| FY2024 | $94.3M | +32.7% |
| FY2023 | $71.0M | -4.4% |
| FY2022 | $74.3M | -58.3% |
| FY2021 | $178.1M | -1.7% |
| FY2020 | $181.1M | +17.8% |
| FY2019 | $153.7M | +16.3% |
| FY2018 | $132.2M | +8.4% |
| FY2017 | $121.9M | +31.3% |
| FY2016 | $92.8M | +2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026